Smith & Nephew

NYSE: SNN · Real-Time Price · USD
29.18
0.22 (0.76%)
At close: Jun 02, 2025, 3:59 PM
29.15
-0.12%
After-hours: Jun 02, 2025, 04:04 PM EDT

Smith & Nephew Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Advanced Wound Management Revenue 1.68B 1.61B 1.51B 1.5B 1.31B 1.38B 1.27B
Advanced Wound Management Revenue Growth +4.67% +6.22% +1.07% +14.20% -5.07% +8.24% n/a
Orthopaedics, Sports Medicine and ENT and Advanced Wound Management Revenue 5.81B 5.55B 5.21B 5.21B n/a n/a n/a
Orthopaedics, Sports Medicine and ENT and Advanced Wound Management Revenue Growth +4.70% +6.40% +0.06% n/a n/a n/a n/a
Orthopaedics, Sports Medicine and Ear Nose and Throat Revenue 4.13B 3.94B 3.7B 3.72B n/a n/a n/a
Orthopaedics, Sports Medicine and Ear Nose and Throat Revenue Growth +4.72% +6.48% -0.35% n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2022 Dec 31, 2021
China Revenue 319M 352M
China Revenue Growth -9.38% n/a
United States Of America Revenue 2.76B 2.66B
United States Of America Revenue Growth +3.99% n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Jun 29, 2024 Dec 31, 2023 Jul 1, 2023 Dec 31, 2022 Jul 2, 2022 Dec 31, 2021 Jul 3, 2021 Dec 31, 2020 Jun 27, 2020 Dec 31, 2019 Jun 29, 2019 Dec 31, 2018 Jun 30, 2018 Dec 31, 2017 Jul 1, 2017 Dec 31, 2016 Jul 2, 2016 Dec 31, 2015 Jun 27, 2015
Selling, General, and Administrative Revenue 1.59B 1.51B 1.43B 1.46B 1.28B 1.41B 1.25B 1.38B 1.19B 1.25B 1.25B 1.28B 1.08B 1.3B 1.2B 1.21B 1.07B 1.19B 1.21B 1.13B
Selling, General, and Administrative Revenue Growth +5.43% +5.30% -1.65% +13.47% -9.00% +12.52% -9.33% +15.93% -4.25% -0.72% -1.88% +17.88% -16.47% +8.52% -1.24% +13.27% -9.70% -1.90% +7.38% n/a
Research and Development Revenue 152M 137M 219M 166M 222M 174M 226M 171M 195M 148M 181M 139M 154M 116M 122M 107M 132M 113M 123M 110M
Research and Development Revenue Growth +10.95% -37.44% +31.93% -25.23% +27.59% -23.01% +32.16% -12.31% +31.76% -18.23% +30.22% -9.74% +32.76% -4.92% +14.02% -18.94% +16.81% -8.13% +11.82% n/a